Global Pertussis Vaccine Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Summary
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
According to APO Research, The global Pertussis Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Pertussis Vaccine include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology, Minhai Biotechnology, KM Biologics and Chengdu Institute of Biological Products, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Pertussis Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pertussis Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Pertussis Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pertussis Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pertussis Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pertussis Vaccine sales, projected growth trends, production technology, application and end-user industry.
Pertussis Vaccine segment by Company
1. To analyze and research the global Pertussis Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Pertussis Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Pertussis Vaccine significant trends, drivers, influence factors in global and regions.
6. To analyze Pertussis Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pertussis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pertussis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pertussis Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pertussis Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pertussis Vaccine industry.
Chapter 3: Detailed analysis of Pertussis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Pertussis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Pertussis Vaccine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
According to APO Research, The global Pertussis Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Pertussis Vaccine include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology, Minhai Biotechnology, KM Biologics and Chengdu Institute of Biological Products, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Pertussis Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pertussis Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Pertussis Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pertussis Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pertussis Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pertussis Vaccine sales, projected growth trends, production technology, application and end-user industry.
Pertussis Vaccine segment by Company
- Sanofi Pasteur
- GSK
- Mitsubishi Tanabe Pharma
- Wuhan Institute of Biological Products
- Walvax Biotechnology
- Minhai Biotechnology
- KM Biologics
- Chengdu Institute of Biological Products
- Whole-cell Vaccines
- Acellular Vaccines
- 12 Months Below
- 12 Months Above
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global Pertussis Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Pertussis Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Pertussis Vaccine significant trends, drivers, influence factors in global and regions.
6. To analyze Pertussis Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pertussis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pertussis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pertussis Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pertussis Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pertussis Vaccine industry.
Chapter 3: Detailed analysis of Pertussis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Pertussis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Pertussis Vaccine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Pertussis Vaccine Sales Value (2019-2030)
1.2.2 Global Pertussis Vaccine Sales Volume (2019-2030)
1.2.3 Global Pertussis Vaccine Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 PERTUSSIS VACCINE MARKET DYNAMICS
2.1 Pertussis Vaccine Industry Trends
2.2 Pertussis Vaccine Industry Drivers
2.3 Pertussis Vaccine Industry Opportunities and Challenges
2.4 Pertussis Vaccine Industry Restraints
3 PERTUSSIS VACCINE MARKET BY COMPANY
3.1 Global Pertussis Vaccine Company Revenue Ranking in 2023
3.2 Global Pertussis Vaccine Revenue by Company (2019-2024)
3.3 Global Pertussis Vaccine Sales Volume by Company (2019-2024)
3.4 Global Pertussis Vaccine Average Price by Company (2019-2024)
3.5 Global Pertussis Vaccine Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Pertussis Vaccine Company Manufacturing Base & Headquarters
3.7 Global Pertussis Vaccine Company, Product Type & Application
3.8 Global Pertussis Vaccine Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Pertussis Vaccine Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Pertussis Vaccine Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 PERTUSSIS VACCINE MARKET BY TYPE
4.1 Pertussis Vaccine Type Introduction
4.1.1 Whole-cell Vaccines
4.1.2 Acellular Vaccines
4.2 Global Pertussis Vaccine Sales Volume by Type
4.2.1 Global Pertussis Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Pertussis Vaccine Sales Volume by Type (2019-2030)
4.2.3 Global Pertussis Vaccine Sales Volume Share by Type (2019-2030)
4.3 Global Pertussis Vaccine Sales Value by Type
4.3.1 Global Pertussis Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Pertussis Vaccine Sales Value by Type (2019-2030)
4.3.3 Global Pertussis Vaccine Sales Value Share by Type (2019-2030)
5 PERTUSSIS VACCINE MARKET BY APPLICATION
5.1 Pertussis Vaccine Application Introduction
5.1.1 12 Months Below
5.1.2 12 Months Above
5.2 Global Pertussis Vaccine Sales Volume by Application
5.2.1 Global Pertussis Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Pertussis Vaccine Sales Volume by Application (2019-2030)
5.2.3 Global Pertussis Vaccine Sales Volume Share by Application (2019-2030)
5.3 Global Pertussis Vaccine Sales Value by Application
5.3.1 Global Pertussis Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Pertussis Vaccine Sales Value by Application (2019-2030)
5.3.3 Global Pertussis Vaccine Sales Value Share by Application (2019-2030)
6 PERTUSSIS VACCINE MARKET BY REGION
6.1 Global Pertussis Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Pertussis Vaccine Sales by Region (2019-2030)
6.2.1 Global Pertussis Vaccine Sales by Region: 2019-2024
6.2.2 Global Pertussis Vaccine Sales by Region (2025-2030)
6.3 Global Pertussis Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Pertussis Vaccine Sales Value by Region (2019-2030)
6.4.1 Global Pertussis Vaccine Sales Value by Region: 2019-2024
6.4.2 Global Pertussis Vaccine Sales Value by Region (2025-2030)
6.5 Global Pertussis Vaccine Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Pertussis Vaccine Sales Value (2019-2030)
6.6.2 North America Pertussis Vaccine Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Pertussis Vaccine Sales Value (2019-2030)
6.7.2 Europe Pertussis Vaccine Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Pertussis Vaccine Sales Value (2019-2030)
6.8.2 Asia-Pacific Pertussis Vaccine Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Pertussis Vaccine Sales Value (2019-2030)
6.9.2 Latin America Pertussis Vaccine Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Pertussis Vaccine Sales Value (2019-2030)
6.10.2 Middle East & Africa Pertussis Vaccine Sales Value Share by Country, 2023 VS 2030
7 PERTUSSIS VACCINE MARKET BY COUNTRY
7.1 Global Pertussis Vaccine Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Pertussis Vaccine Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Pertussis Vaccine Sales by Country (2019-2030)
7.3.1 Global Pertussis Vaccine Sales by Country (2019-2024)
7.3.2 Global Pertussis Vaccine Sales by Country (2025-2030)
7.4 Global Pertussis Vaccine Sales Value by Country (2019-2030)
7.4.1 Global Pertussis Vaccine Sales Value by Country (2019-2024)
7.4.2 Global Pertussis Vaccine Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.5.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.6.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.7.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.8.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.9.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.10.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.11.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.12.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.13.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.14.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.15.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.16.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.17.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.18.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.19.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.20.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.21.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.22.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.23.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Sanofi Pasteur
8.1.1 Sanofi Pasteur Comapny Information
8.1.2 Sanofi Pasteur Business Overview
8.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Value and Gross Margin (2019-2024)
8.1.4 Sanofi Pasteur Pertussis Vaccine Product Portfolio
8.1.5 Sanofi Pasteur Recent Developments
8.2 GSK
8.2.1 GSK Comapny Information
8.2.2 GSK Business Overview
8.2.3 GSK Pertussis Vaccine Sales, Value and Gross Margin (2019-2024)
8.2.4 GSK Pertussis Vaccine Product Portfolio
8.2.5 GSK Recent Developments
8.3 Mitsubishi Tanabe Pharma
8.3.1 Mitsubishi Tanabe Pharma Comapny Information
8.3.2 Mitsubishi Tanabe Pharma Business Overview
8.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Value and Gross Margin (2019-2024)
8.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
8.3.5 Mitsubishi Tanabe Pharma Recent Developments
8.4 Wuhan Institute of Biological Products
8.4.1 Wuhan Institute of Biological Products Comapny Information
8.4.2 Wuhan Institute of Biological Products Business Overview
8.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Value and Gross Margin (2019-2024)
8.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
8.4.5 Wuhan Institute of Biological Products Recent Developments
8.5 Walvax Biotechnology
8.5.1 Walvax Biotechnology Comapny Information
8.5.2 Walvax Biotechnology Business Overview
8.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Value and Gross Margin (2019-2024)
8.5.4 Walvax Biotechnology Pertussis Vaccine Product Portfolio
8.5.5 Walvax Biotechnology Recent Developments
8.6 Minhai Biotechnology
8.6.1 Minhai Biotechnology Comapny Information
8.6.2 Minhai Biotechnology Business Overview
8.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Value and Gross Margin (2019-2024)
8.6.4 Minhai Biotechnology Pertussis Vaccine Product Portfolio
8.6.5 Minhai Biotechnology Recent Developments
8.7 KM Biologics
8.7.1 KM Biologics Comapny Information
8.7.2 KM Biologics Business Overview
8.7.3 KM Biologics Pertussis Vaccine Sales, Value and Gross Margin (2019-2024)
8.7.4 KM Biologics Pertussis Vaccine Product Portfolio
8.7.5 KM Biologics Recent Developments
8.8 Chengdu Institute of Biological Products
8.8.1 Chengdu Institute of Biological Products Comapny Information
8.8.2 Chengdu Institute of Biological Products Business Overview
8.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Value and Gross Margin (2019-2024)
8.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
8.8.5 Chengdu Institute of Biological Products Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Pertussis Vaccine Value Chain Analysis
9.1.1 Pertussis Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Pertussis Vaccine Sales Mode & Process
9.2 Pertussis Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Pertussis Vaccine Distributors
9.2.3 Pertussis Vaccine Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Pertussis Vaccine Sales Value (2019-2030)
1.2.2 Global Pertussis Vaccine Sales Volume (2019-2030)
1.2.3 Global Pertussis Vaccine Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 PERTUSSIS VACCINE MARKET DYNAMICS
2.1 Pertussis Vaccine Industry Trends
2.2 Pertussis Vaccine Industry Drivers
2.3 Pertussis Vaccine Industry Opportunities and Challenges
2.4 Pertussis Vaccine Industry Restraints
3 PERTUSSIS VACCINE MARKET BY COMPANY
3.1 Global Pertussis Vaccine Company Revenue Ranking in 2023
3.2 Global Pertussis Vaccine Revenue by Company (2019-2024)
3.3 Global Pertussis Vaccine Sales Volume by Company (2019-2024)
3.4 Global Pertussis Vaccine Average Price by Company (2019-2024)
3.5 Global Pertussis Vaccine Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Pertussis Vaccine Company Manufacturing Base & Headquarters
3.7 Global Pertussis Vaccine Company, Product Type & Application
3.8 Global Pertussis Vaccine Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Pertussis Vaccine Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Pertussis Vaccine Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 PERTUSSIS VACCINE MARKET BY TYPE
4.1 Pertussis Vaccine Type Introduction
4.1.1 Whole-cell Vaccines
4.1.2 Acellular Vaccines
4.2 Global Pertussis Vaccine Sales Volume by Type
4.2.1 Global Pertussis Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Pertussis Vaccine Sales Volume by Type (2019-2030)
4.2.3 Global Pertussis Vaccine Sales Volume Share by Type (2019-2030)
4.3 Global Pertussis Vaccine Sales Value by Type
4.3.1 Global Pertussis Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Pertussis Vaccine Sales Value by Type (2019-2030)
4.3.3 Global Pertussis Vaccine Sales Value Share by Type (2019-2030)
5 PERTUSSIS VACCINE MARKET BY APPLICATION
5.1 Pertussis Vaccine Application Introduction
5.1.1 12 Months Below
5.1.2 12 Months Above
5.2 Global Pertussis Vaccine Sales Volume by Application
5.2.1 Global Pertussis Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Pertussis Vaccine Sales Volume by Application (2019-2030)
5.2.3 Global Pertussis Vaccine Sales Volume Share by Application (2019-2030)
5.3 Global Pertussis Vaccine Sales Value by Application
5.3.1 Global Pertussis Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Pertussis Vaccine Sales Value by Application (2019-2030)
5.3.3 Global Pertussis Vaccine Sales Value Share by Application (2019-2030)
6 PERTUSSIS VACCINE MARKET BY REGION
6.1 Global Pertussis Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Pertussis Vaccine Sales by Region (2019-2030)
6.2.1 Global Pertussis Vaccine Sales by Region: 2019-2024
6.2.2 Global Pertussis Vaccine Sales by Region (2025-2030)
6.3 Global Pertussis Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Pertussis Vaccine Sales Value by Region (2019-2030)
6.4.1 Global Pertussis Vaccine Sales Value by Region: 2019-2024
6.4.2 Global Pertussis Vaccine Sales Value by Region (2025-2030)
6.5 Global Pertussis Vaccine Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Pertussis Vaccine Sales Value (2019-2030)
6.6.2 North America Pertussis Vaccine Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Pertussis Vaccine Sales Value (2019-2030)
6.7.2 Europe Pertussis Vaccine Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Pertussis Vaccine Sales Value (2019-2030)
6.8.2 Asia-Pacific Pertussis Vaccine Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Pertussis Vaccine Sales Value (2019-2030)
6.9.2 Latin America Pertussis Vaccine Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Pertussis Vaccine Sales Value (2019-2030)
6.10.2 Middle East & Africa Pertussis Vaccine Sales Value Share by Country, 2023 VS 2030
7 PERTUSSIS VACCINE MARKET BY COUNTRY
7.1 Global Pertussis Vaccine Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Pertussis Vaccine Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Pertussis Vaccine Sales by Country (2019-2030)
7.3.1 Global Pertussis Vaccine Sales by Country (2019-2024)
7.3.2 Global Pertussis Vaccine Sales by Country (2025-2030)
7.4 Global Pertussis Vaccine Sales Value by Country (2019-2030)
7.4.1 Global Pertussis Vaccine Sales Value by Country (2019-2024)
7.4.2 Global Pertussis Vaccine Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.5.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.6.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.7.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.8.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.9.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.10.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.11.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.12.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.13.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.14.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.15.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.16.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.17.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.18.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.19.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.20.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.21.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.22.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.23.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Sanofi Pasteur
8.1.1 Sanofi Pasteur Comapny Information
8.1.2 Sanofi Pasteur Business Overview
8.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Value and Gross Margin (2019-2024)
8.1.4 Sanofi Pasteur Pertussis Vaccine Product Portfolio
8.1.5 Sanofi Pasteur Recent Developments
8.2 GSK
8.2.1 GSK Comapny Information
8.2.2 GSK Business Overview
8.2.3 GSK Pertussis Vaccine Sales, Value and Gross Margin (2019-2024)
8.2.4 GSK Pertussis Vaccine Product Portfolio
8.2.5 GSK Recent Developments
8.3 Mitsubishi Tanabe Pharma
8.3.1 Mitsubishi Tanabe Pharma Comapny Information
8.3.2 Mitsubishi Tanabe Pharma Business Overview
8.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Value and Gross Margin (2019-2024)
8.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
8.3.5 Mitsubishi Tanabe Pharma Recent Developments
8.4 Wuhan Institute of Biological Products
8.4.1 Wuhan Institute of Biological Products Comapny Information
8.4.2 Wuhan Institute of Biological Products Business Overview
8.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Value and Gross Margin (2019-2024)
8.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
8.4.5 Wuhan Institute of Biological Products Recent Developments
8.5 Walvax Biotechnology
8.5.1 Walvax Biotechnology Comapny Information
8.5.2 Walvax Biotechnology Business Overview
8.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Value and Gross Margin (2019-2024)
8.5.4 Walvax Biotechnology Pertussis Vaccine Product Portfolio
8.5.5 Walvax Biotechnology Recent Developments
8.6 Minhai Biotechnology
8.6.1 Minhai Biotechnology Comapny Information
8.6.2 Minhai Biotechnology Business Overview
8.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Value and Gross Margin (2019-2024)
8.6.4 Minhai Biotechnology Pertussis Vaccine Product Portfolio
8.6.5 Minhai Biotechnology Recent Developments
8.7 KM Biologics
8.7.1 KM Biologics Comapny Information
8.7.2 KM Biologics Business Overview
8.7.3 KM Biologics Pertussis Vaccine Sales, Value and Gross Margin (2019-2024)
8.7.4 KM Biologics Pertussis Vaccine Product Portfolio
8.7.5 KM Biologics Recent Developments
8.8 Chengdu Institute of Biological Products
8.8.1 Chengdu Institute of Biological Products Comapny Information
8.8.2 Chengdu Institute of Biological Products Business Overview
8.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Value and Gross Margin (2019-2024)
8.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
8.8.5 Chengdu Institute of Biological Products Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Pertussis Vaccine Value Chain Analysis
9.1.1 Pertussis Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Pertussis Vaccine Sales Mode & Process
9.2 Pertussis Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Pertussis Vaccine Distributors
9.2.3 Pertussis Vaccine Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
LIST OF TABLES
Table 1. Pertussis Vaccine Industry Trends
Table 2. Pertussis Vaccine Industry Drivers
Table 3. Pertussis Vaccine Industry Opportunities and Challenges
Table 4. Pertussis Vaccine Industry Restraints
Table 5. Global Pertussis Vaccine Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Pertussis Vaccine Revenue Share by Company (2019-2024)
Table 7. Global Pertussis Vaccine Sales Volume by Company (M Doses) & (2019-2024)
Table 8. Global Pertussis Vaccine Sales Volume Share by Company (2019-2024)
Table 9. Global Pertussis Vaccine Average Price (USD/Doses) of Company (2019-2024)
Table 10. Global Pertussis Vaccine Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 11. Global Pertussis Vaccine Key Company Manufacturing Base & Headquarters
Table 12. Global Pertussis Vaccine Company, Product Type & Application
Table 13. Global Pertussis Vaccine Company Commercialization Time
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global Pertussis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Major Companies of Whole-cell Vaccines
Table 18. Major Companies of Acellular Vaccines
Table 19. Global Pertussis Vaccine Sales Volume by Type 2019 VS 2023 VS 2030 (M Doses)
Table 20. Global Pertussis Vaccine Sales Volume by Type (2019-2024) & (M Doses)
Table 21. Global Pertussis Vaccine Sales Volume by Type (2025-2030) & (M Doses)
Table 22. Global Pertussis Vaccine Sales Volume Share by Type (2019-2024)
Table 23. Global Pertussis Vaccine Sales Volume Share by Type (2025-2030)
Table 24. Global Pertussis Vaccine Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 25. Global Pertussis Vaccine Sales Value by Type (2019-2024) & (US$ Million)
Table 26. Global Pertussis Vaccine Sales Value by Type (2025-2030) & (US$ Million)
Table 27. Global Pertussis Vaccine Sales Value Share by Type (2019-2024)
Table 28. Global Pertussis Vaccine Sales Value Share by Type (2025-2030)
Table 29. Major Companies of 12 Months Below
Table 30. Major Companies of 12 Months Above
Table 31. Global Pertussis Vaccine Sales Volume by Application 2019 VS 2023 VS 2030 (M Doses)
Table 32. Global Pertussis Vaccine Sales Volume by Application (2019-2024) & (M Doses)
Table 33. Global Pertussis Vaccine Sales Volume by Application (2025-2030) & (M Doses)
Table 34. Global Pertussis Vaccine Sales Volume Share by Application (2019-2024)
Table 35. Global Pertussis Vaccine Sales Volume Share by Application (2025-2030)
Table 36. Global Pertussis Vaccine Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 37. Global Pertussis Vaccine Sales Value by Application (2019-2024) & (US$ Million)
Table 38. Global Pertussis Vaccine Sales Value by Application (2025-2030) & (US$ Million)
Table 39. Global Pertussis Vaccine Sales Value Share by Application (2019-2024)
Table 40. Global Pertussis Vaccine Sales Value Share by Application (2025-2030)
Table 41. Global Pertussis Vaccine Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 42. Global Pertussis Vaccine Sales by Region (2019-2024) & (M Doses)
Table 43. Global Pertussis Vaccine Sales Market Share by Region (2019-2024)
Table 44. Global Pertussis Vaccine Sales by Region (2025-2030) & (M Doses)
Table 45. Global Pertussis Vaccine Sales Market Share by Region (2025-2030)
Table 46. Global Pertussis Vaccine Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 47. Global Pertussis Vaccine Sales Value by Region (2019-2024) & (US$ Million)
Table 48. Global Pertussis Vaccine Sales Value Share by Region (2019-2024)
Table 49. Global Pertussis Vaccine Sales Value by Region (2025-2030) & (US$ Million)
Table 50. Global Pertussis Vaccine Sales Value Share by Region (2025-2030)
Table 51. Global Pertussis Vaccine Market Average Price (USD/Doses) by Region (2019-2024)
Table 52. Global Pertussis Vaccine Market Average Price (USD/Doses) by Region (2025-2030)
Table 53. Global Pertussis Vaccine Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 54. Global Pertussis Vaccine Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 55. Global Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 56. Global Pertussis Vaccine Sales Market Share by Country (2019-2024)
Table 57. Global Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)
Table 58. Global Pertussis Vaccine Sales Market Share by Country (2025-2030)
Table 59. Global Pertussis Vaccine Sales Value by Country (2019-2024) & (US$ Million)
Table 60. Global Pertussis Vaccine Sales Value Market Share by Country (2019-2024)
Table 61. Global Pertussis Vaccine Sales Value by Country (2025-2030) & (US$ Million)
Table 62. Global Pertussis Vaccine Sales Value Market Share by Country (2025-2030)
Table 63. Sanofi Pasteur Company Information
Table 64. Sanofi Pasteur Business Overview
Table 65. Sanofi Pasteur Pertussis Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 66. Sanofi Pasteur Pertussis Vaccine Product Portfolio
Table 67. Sanofi Pasteur Recent Development
Table 68. GSK Company Information
Table 69. GSK Business Overview
Table 70. GSK Pertussis Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 71. GSK Pertussis Vaccine Product Portfolio
Table 72. GSK Recent Development
Table 73. Mitsubishi Tanabe Pharma Company Information
Table 74. Mitsubishi Tanabe Pharma Business Overview
Table 75. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 76. Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
Table 77. Mitsubishi Tanabe Pharma Recent Development
Table 78. Wuhan Institute of Biological Products Company Information
Table 79. Wuhan Institute of Biological Products Business Overview
Table 80. Wuhan Institute of Biological Products Pertussis Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 81. Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
Table 82. Wuhan Institute of Biological Products Recent Development
Table 83. Walvax Biotechnology Company Information
Table 84. Walvax Biotechnology Business Overview
Table 85. Walvax Biotechnology Pertussis Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 86. Walvax Biotechnology Pertussis Vaccine Product Portfolio
Table 87. Walvax Biotechnology Recent Development
Table 88. Minhai Biotechnology Company Information
Table 89. Minhai Biotechnology Business Overview
Table 90. Minhai Biotechnology Pertussis Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 91. Minhai Biotechnology Pertussis Vaccine Product Portfolio
Table 92. Minhai Biotechnology Recent Development
Table 93. KM Biologics Company Information
Table 94. KM Biologics Business Overview
Table 95. KM Biologics Pertussis Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 96. KM Biologics Pertussis Vaccine Product Portfolio
Table 97. KM Biologics Recent Development
Table 98. Chengdu Institute of Biological Products Company Information
Table 99. Chengdu Institute of Biological Products Business Overview
Table 100. Chengdu Institute of Biological Products Pertussis Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 101. Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
Table 102. Chengdu Institute of Biological Products Recent Development
Table 103. Key Raw Materials
Table 104. Raw Materials Key Suppliers
Table 105. Pertussis Vaccine Distributors List
Table 106. Pertussis Vaccine Customers List
Table 107. Research Programs/Design for This Report
Table 108. Authors List of This Report
Table 109. Secondary Sources
Table 110. Primary Sources
Table 1. Pertussis Vaccine Industry Trends
Table 2. Pertussis Vaccine Industry Drivers
Table 3. Pertussis Vaccine Industry Opportunities and Challenges
Table 4. Pertussis Vaccine Industry Restraints
Table 5. Global Pertussis Vaccine Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Pertussis Vaccine Revenue Share by Company (2019-2024)
Table 7. Global Pertussis Vaccine Sales Volume by Company (M Doses) & (2019-2024)
Table 8. Global Pertussis Vaccine Sales Volume Share by Company (2019-2024)
Table 9. Global Pertussis Vaccine Average Price (USD/Doses) of Company (2019-2024)
Table 10. Global Pertussis Vaccine Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 11. Global Pertussis Vaccine Key Company Manufacturing Base & Headquarters
Table 12. Global Pertussis Vaccine Company, Product Type & Application
Table 13. Global Pertussis Vaccine Company Commercialization Time
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global Pertussis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Major Companies of Whole-cell Vaccines
Table 18. Major Companies of Acellular Vaccines
Table 19. Global Pertussis Vaccine Sales Volume by Type 2019 VS 2023 VS 2030 (M Doses)
Table 20. Global Pertussis Vaccine Sales Volume by Type (2019-2024) & (M Doses)
Table 21. Global Pertussis Vaccine Sales Volume by Type (2025-2030) & (M Doses)
Table 22. Global Pertussis Vaccine Sales Volume Share by Type (2019-2024)
Table 23. Global Pertussis Vaccine Sales Volume Share by Type (2025-2030)
Table 24. Global Pertussis Vaccine Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 25. Global Pertussis Vaccine Sales Value by Type (2019-2024) & (US$ Million)
Table 26. Global Pertussis Vaccine Sales Value by Type (2025-2030) & (US$ Million)
Table 27. Global Pertussis Vaccine Sales Value Share by Type (2019-2024)
Table 28. Global Pertussis Vaccine Sales Value Share by Type (2025-2030)
Table 29. Major Companies of 12 Months Below
Table 30. Major Companies of 12 Months Above
Table 31. Global Pertussis Vaccine Sales Volume by Application 2019 VS 2023 VS 2030 (M Doses)
Table 32. Global Pertussis Vaccine Sales Volume by Application (2019-2024) & (M Doses)
Table 33. Global Pertussis Vaccine Sales Volume by Application (2025-2030) & (M Doses)
Table 34. Global Pertussis Vaccine Sales Volume Share by Application (2019-2024)
Table 35. Global Pertussis Vaccine Sales Volume Share by Application (2025-2030)
Table 36. Global Pertussis Vaccine Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 37. Global Pertussis Vaccine Sales Value by Application (2019-2024) & (US$ Million)
Table 38. Global Pertussis Vaccine Sales Value by Application (2025-2030) & (US$ Million)
Table 39. Global Pertussis Vaccine Sales Value Share by Application (2019-2024)
Table 40. Global Pertussis Vaccine Sales Value Share by Application (2025-2030)
Table 41. Global Pertussis Vaccine Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 42. Global Pertussis Vaccine Sales by Region (2019-2024) & (M Doses)
Table 43. Global Pertussis Vaccine Sales Market Share by Region (2019-2024)
Table 44. Global Pertussis Vaccine Sales by Region (2025-2030) & (M Doses)
Table 45. Global Pertussis Vaccine Sales Market Share by Region (2025-2030)
Table 46. Global Pertussis Vaccine Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 47. Global Pertussis Vaccine Sales Value by Region (2019-2024) & (US$ Million)
Table 48. Global Pertussis Vaccine Sales Value Share by Region (2019-2024)
Table 49. Global Pertussis Vaccine Sales Value by Region (2025-2030) & (US$ Million)
Table 50. Global Pertussis Vaccine Sales Value Share by Region (2025-2030)
Table 51. Global Pertussis Vaccine Market Average Price (USD/Doses) by Region (2019-2024)
Table 52. Global Pertussis Vaccine Market Average Price (USD/Doses) by Region (2025-2030)
Table 53. Global Pertussis Vaccine Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 54. Global Pertussis Vaccine Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 55. Global Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 56. Global Pertussis Vaccine Sales Market Share by Country (2019-2024)
Table 57. Global Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)
Table 58. Global Pertussis Vaccine Sales Market Share by Country (2025-2030)
Table 59. Global Pertussis Vaccine Sales Value by Country (2019-2024) & (US$ Million)
Table 60. Global Pertussis Vaccine Sales Value Market Share by Country (2019-2024)
Table 61. Global Pertussis Vaccine Sales Value by Country (2025-2030) & (US$ Million)
Table 62. Global Pertussis Vaccine Sales Value Market Share by Country (2025-2030)
Table 63. Sanofi Pasteur Company Information
Table 64. Sanofi Pasteur Business Overview
Table 65. Sanofi Pasteur Pertussis Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 66. Sanofi Pasteur Pertussis Vaccine Product Portfolio
Table 67. Sanofi Pasteur Recent Development
Table 68. GSK Company Information
Table 69. GSK Business Overview
Table 70. GSK Pertussis Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 71. GSK Pertussis Vaccine Product Portfolio
Table 72. GSK Recent Development
Table 73. Mitsubishi Tanabe Pharma Company Information
Table 74. Mitsubishi Tanabe Pharma Business Overview
Table 75. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 76. Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
Table 77. Mitsubishi Tanabe Pharma Recent Development
Table 78. Wuhan Institute of Biological Products Company Information
Table 79. Wuhan Institute of Biological Products Business Overview
Table 80. Wuhan Institute of Biological Products Pertussis Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 81. Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
Table 82. Wuhan Institute of Biological Products Recent Development
Table 83. Walvax Biotechnology Company Information
Table 84. Walvax Biotechnology Business Overview
Table 85. Walvax Biotechnology Pertussis Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 86. Walvax Biotechnology Pertussis Vaccine Product Portfolio
Table 87. Walvax Biotechnology Recent Development
Table 88. Minhai Biotechnology Company Information
Table 89. Minhai Biotechnology Business Overview
Table 90. Minhai Biotechnology Pertussis Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 91. Minhai Biotechnology Pertussis Vaccine Product Portfolio
Table 92. Minhai Biotechnology Recent Development
Table 93. KM Biologics Company Information
Table 94. KM Biologics Business Overview
Table 95. KM Biologics Pertussis Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 96. KM Biologics Pertussis Vaccine Product Portfolio
Table 97. KM Biologics Recent Development
Table 98. Chengdu Institute of Biological Products Company Information
Table 99. Chengdu Institute of Biological Products Business Overview
Table 100. Chengdu Institute of Biological Products Pertussis Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 101. Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
Table 102. Chengdu Institute of Biological Products Recent Development
Table 103. Key Raw Materials
Table 104. Raw Materials Key Suppliers
Table 105. Pertussis Vaccine Distributors List
Table 106. Pertussis Vaccine Customers List
Table 107. Research Programs/Design for This Report
Table 108. Authors List of This Report
Table 109. Secondary Sources
Table 110. Primary Sources
LIST OF FIGURES
Figure 1. Pertussis Vaccine Product Picture
Figure 2. Global Pertussis Vaccine Sales Value (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Pertussis Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Pertussis Vaccine Sales (2019-2030) & (M Doses)
Figure 5. Global Pertussis Vaccine Sales Average Price (USD/Doses) & (2019-2030)
Figure 6. Global Pertussis Vaccine Company Revenue Ranking in 2023 (US$ Million)
Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 9. Whole-cell Vaccines Picture
Figure 10. Acellular Vaccines Picture
Figure 11. Global Pertussis Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 12. Global Pertussis Vaccine Sales Volume Share 2019 VS 2023 VS 2030
Figure 13. Global Pertussis Vaccine Sales Volume Share by Type (2019-2030)
Figure 14. Global Pertussis Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Pertussis Vaccine Sales Value Share 2019 VS 2023 VS 2030
Figure 16. Global Pertussis Vaccine Sales Value Share by Type (2019-2030)
Figure 17. 12 Months Below Picture
Figure 18. 12 Months Above Picture
Figure 19. Global Pertussis Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 20. Global Pertussis Vaccine Sales Volume Share 2019 VS 2023 VS 2030
Figure 21. Global Pertussis Vaccine Sales Volume Share by Application (2019-2030)
Figure 22. Global Pertussis Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Pertussis Vaccine Sales Value Share 2019 VS 2023 VS 2030
Figure 24. Global Pertussis Vaccine Sales Value Share by Application (2019-2030)
Figure 25. Global Pertussis Vaccine Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Figure 26. Global Pertussis Vaccine Sales Market Share by Region: 2019 VS 2023 VS 2030
Figure 27. Global Pertussis Vaccine Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 28. Global Pertussis Vaccine Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 29. North America Pertussis Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 30. North America Pertussis Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 31. Europe Pertussis Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 32. Europe Pertussis Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 33. Asia-Pacific Pertussis Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Pertussis Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 35. Latin America Pertussis Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 36. Latin America Pertussis Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 37. Middle East & Africa Pertussis Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 38. Middle East & Africa Pertussis Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 39. USA Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 40. USA Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 41. USA Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 42. Canada Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 43. Canada Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 44. Canada Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 45. Germany Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 46. Germany Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 47. Germany Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 48. France Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 49. France Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 50. France Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 51. U.K. Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 52. U.K. Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 53. U.K. Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 54. Italy Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 55. Italy Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 56. Italy Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 57. Netherlands Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 58. Netherlands Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 59. Netherlands Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 60. Nordic Countries Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 61. Nordic Countries Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 62. Nordic Countries Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 63. China Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 64. China Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 65. China Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 66. Japan Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 67. Japan Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 68. Japan Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 69. South Korea Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 70. South Korea Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 71. South Korea Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 72. Southeast Asia Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 73. Southeast Asia Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 74. Southeast Asia Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 75. India Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 76. India Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 77. India Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 78. Australia Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 79. Australia Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 80. Australia Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 81. Mexico Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 82. Mexico Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 83. Mexico Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 84. Brazil Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 85. Brazil Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 86. Brazil Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 87. Turkey Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 88. Turkey Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 89. Turkey Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 90. Saudi Arabia Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 91. Saudi Arabia Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 92. Saudi Arabia Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 93. UAE Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 94. UAE Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 95. UAE Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 96. Pertussis Vaccine Value Chain
Figure 97. Manufacturing Cost Structure
Figure 98. Pertussis Vaccine Sales Mode & Process
Figure 99. Direct Comparison with Distribution Share
Figure 100. Distributors Profiles
Figure 101. Years Considered
Figure 102. Research Process
Figure 103. Key Executives Interviewed
Figure 1. Pertussis Vaccine Product Picture
Figure 2. Global Pertussis Vaccine Sales Value (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Pertussis Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Pertussis Vaccine Sales (2019-2030) & (M Doses)
Figure 5. Global Pertussis Vaccine Sales Average Price (USD/Doses) & (2019-2030)
Figure 6. Global Pertussis Vaccine Company Revenue Ranking in 2023 (US$ Million)
Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 9. Whole-cell Vaccines Picture
Figure 10. Acellular Vaccines Picture
Figure 11. Global Pertussis Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 12. Global Pertussis Vaccine Sales Volume Share 2019 VS 2023 VS 2030
Figure 13. Global Pertussis Vaccine Sales Volume Share by Type (2019-2030)
Figure 14. Global Pertussis Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Pertussis Vaccine Sales Value Share 2019 VS 2023 VS 2030
Figure 16. Global Pertussis Vaccine Sales Value Share by Type (2019-2030)
Figure 17. 12 Months Below Picture
Figure 18. 12 Months Above Picture
Figure 19. Global Pertussis Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 20. Global Pertussis Vaccine Sales Volume Share 2019 VS 2023 VS 2030
Figure 21. Global Pertussis Vaccine Sales Volume Share by Application (2019-2030)
Figure 22. Global Pertussis Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Pertussis Vaccine Sales Value Share 2019 VS 2023 VS 2030
Figure 24. Global Pertussis Vaccine Sales Value Share by Application (2019-2030)
Figure 25. Global Pertussis Vaccine Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Figure 26. Global Pertussis Vaccine Sales Market Share by Region: 2019 VS 2023 VS 2030
Figure 27. Global Pertussis Vaccine Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 28. Global Pertussis Vaccine Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 29. North America Pertussis Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 30. North America Pertussis Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 31. Europe Pertussis Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 32. Europe Pertussis Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 33. Asia-Pacific Pertussis Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Pertussis Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 35. Latin America Pertussis Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 36. Latin America Pertussis Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 37. Middle East & Africa Pertussis Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 38. Middle East & Africa Pertussis Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 39. USA Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 40. USA Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 41. USA Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 42. Canada Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 43. Canada Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 44. Canada Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 45. Germany Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 46. Germany Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 47. Germany Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 48. France Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 49. France Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 50. France Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 51. U.K. Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 52. U.K. Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 53. U.K. Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 54. Italy Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 55. Italy Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 56. Italy Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 57. Netherlands Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 58. Netherlands Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 59. Netherlands Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 60. Nordic Countries Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 61. Nordic Countries Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 62. Nordic Countries Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 63. China Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 64. China Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 65. China Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 66. Japan Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 67. Japan Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 68. Japan Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 69. South Korea Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 70. South Korea Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 71. South Korea Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 72. Southeast Asia Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 73. Southeast Asia Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 74. Southeast Asia Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 75. India Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 76. India Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 77. India Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 78. Australia Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 79. Australia Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 80. Australia Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 81. Mexico Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 82. Mexico Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 83. Mexico Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 84. Brazil Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 85. Brazil Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 86. Brazil Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 87. Turkey Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 88. Turkey Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 89. Turkey Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 90. Saudi Arabia Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 91. Saudi Arabia Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 92. Saudi Arabia Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 93. UAE Pertussis Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 94. UAE Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 95. UAE Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 96. Pertussis Vaccine Value Chain
Figure 97. Manufacturing Cost Structure
Figure 98. Pertussis Vaccine Sales Mode & Process
Figure 99. Direct Comparison with Distribution Share
Figure 100. Distributors Profiles
Figure 101. Years Considered
Figure 102. Research Process
Figure 103. Key Executives Interviewed
